Maika Kummel , Emma Luther-Tontasse , Jaana Koskenniemi , Tero Vahlberg , Matti Viitanen , Jouni Johansson , Päivi Korhonen , Laura Viikari , Marika Salminen
{"title":"国家治疗指南在老年 2 型糖尿病患者中执行不力--呼吁采取行动!","authors":"Maika Kummel , Emma Luther-Tontasse , Jaana Koskenniemi , Tero Vahlberg , Matti Viitanen , Jouni Johansson , Päivi Korhonen , Laura Viikari , Marika Salminen","doi":"10.1016/j.pcd.2024.01.012","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To assess risk factors and factors associated with nonachievement of the treatment target levels among 75-year-old Finns with type 2 diabetes (T2D).</p></div><div><h3>Design</h3><p>Cross-sectional study.</p></div><div><h3>Setting</h3><p>Outpatient<u><u>.</u></u></p></div><div><h3>Subjects</h3><p>Seventy-five-year-old participants of the Turku Senior Health Clinic Study (N = 1296) with T2D (n = 247).</p><p>Main outcome measures:</p><p>Nonachievement of fasting blood glucose (FBG), low-density lipoprotein (LDL-C), and blood pressure (BP) levels set by the national treatment guidelines.</p></div><div><h3>Results</h3><p>Nonachievement rates of FBG, BP and LDL-C were 47%, 85%, and 47%, respectively. Non-usage of T2D medication was negatively (adjusted OR 0.38, 95% CI 0.16–0.88) and central obesity positively (1.88, 1.09–3.24) related to nonachievement of FBG target level; alcohol use was positively (3.71, 1.04–13.16) and decreased self-rated health negatively (0.34, 0.12–0.97) related to the nonachievement of BP target level. Nonachievement of LDL-C target level was positively related to poor financial status (3.50, 1.19–10.28) and non-use of lipid-lowering medication (7.70, 4.07–14.56)<u><u>.</u></u></p></div><div><h3>Conclusions</h3><p>Nonachievement rates of the national treatment goals were high among older T2D patients, and nonachievement was related to use of medication, obesity, alcohol use, poor health, and poor financial status. We emphasize the importance of customized target setting by risk factor levels and active treatment.</p></div>","PeriodicalId":48997,"journal":{"name":"Primary Care Diabetes","volume":"18 2","pages":"Pages 126-131"},"PeriodicalIF":2.6000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"National treatment guidelines poorly achieved among older subjects with type 2 diabetes – call to action!\",\"authors\":\"Maika Kummel , Emma Luther-Tontasse , Jaana Koskenniemi , Tero Vahlberg , Matti Viitanen , Jouni Johansson , Päivi Korhonen , Laura Viikari , Marika Salminen\",\"doi\":\"10.1016/j.pcd.2024.01.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To assess risk factors and factors associated with nonachievement of the treatment target levels among 75-year-old Finns with type 2 diabetes (T2D).</p></div><div><h3>Design</h3><p>Cross-sectional study.</p></div><div><h3>Setting</h3><p>Outpatient<u><u>.</u></u></p></div><div><h3>Subjects</h3><p>Seventy-five-year-old participants of the Turku Senior Health Clinic Study (N = 1296) with T2D (n = 247).</p><p>Main outcome measures:</p><p>Nonachievement of fasting blood glucose (FBG), low-density lipoprotein (LDL-C), and blood pressure (BP) levels set by the national treatment guidelines.</p></div><div><h3>Results</h3><p>Nonachievement rates of FBG, BP and LDL-C were 47%, 85%, and 47%, respectively. Non-usage of T2D medication was negatively (adjusted OR 0.38, 95% CI 0.16–0.88) and central obesity positively (1.88, 1.09–3.24) related to nonachievement of FBG target level; alcohol use was positively (3.71, 1.04–13.16) and decreased self-rated health negatively (0.34, 0.12–0.97) related to the nonachievement of BP target level. Nonachievement of LDL-C target level was positively related to poor financial status (3.50, 1.19–10.28) and non-use of lipid-lowering medication (7.70, 4.07–14.56)<u><u>.</u></u></p></div><div><h3>Conclusions</h3><p>Nonachievement rates of the national treatment goals were high among older T2D patients, and nonachievement was related to use of medication, obesity, alcohol use, poor health, and poor financial status. We emphasize the importance of customized target setting by risk factor levels and active treatment.</p></div>\",\"PeriodicalId\":48997,\"journal\":{\"name\":\"Primary Care Diabetes\",\"volume\":\"18 2\",\"pages\":\"Pages 126-131\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Primary Care Diabetes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1751991824000093\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Care Diabetes","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1751991824000093","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
目的:评估 75 岁芬兰 2 型糖尿病患者未达到治疗目标水平的风险因素和相关因素:评估 75 岁芬兰 2 型糖尿病(T2D)患者未达到治疗目标水平的风险因素和相关因素:横断面研究:受试者图尔库老年健康诊所研究的 75 岁 T2D 患者(1296 人)(247 人):未达到国家治疗指南规定的空腹血糖(FBG)、低密度脂蛋白(LDL-C)和血压(BP)水平:未达到 FBG、BP 和 LDL-C 水平的比例分别为 47%、85% 和 47%。未使用 T2D 药物与未达到 FBG 目标水平呈负相关(调整 OR 0.38,95% CI 0.16-0.88),中心性肥胖与未达到 FBG 目标水平呈正相关(1.88,1.09-3.24);饮酒与未达到 BP 目标水平呈正相关(3.71,1.04-13.16),自评健康水平下降与未达到 BP 目标水平呈负相关(0.34,0.12-0.97)。未达到低密度脂蛋白胆固醇目标水平与经济状况不佳(3.50,1.19-10.28)和未使用降脂药物(7.70,4.07-14.56)呈正相关:老年 T2D 患者未达到国家治疗目标的比例很高,未达到目标与使用药物、肥胖、酗酒、健康状况差和经济状况差有关。我们强调根据风险因素水平和积极治疗情况制定个性化目标的重要性。
National treatment guidelines poorly achieved among older subjects with type 2 diabetes – call to action!
Objective
To assess risk factors and factors associated with nonachievement of the treatment target levels among 75-year-old Finns with type 2 diabetes (T2D).
Design
Cross-sectional study.
Setting
Outpatient.
Subjects
Seventy-five-year-old participants of the Turku Senior Health Clinic Study (N = 1296) with T2D (n = 247).
Main outcome measures:
Nonachievement of fasting blood glucose (FBG), low-density lipoprotein (LDL-C), and blood pressure (BP) levels set by the national treatment guidelines.
Results
Nonachievement rates of FBG, BP and LDL-C were 47%, 85%, and 47%, respectively. Non-usage of T2D medication was negatively (adjusted OR 0.38, 95% CI 0.16–0.88) and central obesity positively (1.88, 1.09–3.24) related to nonachievement of FBG target level; alcohol use was positively (3.71, 1.04–13.16) and decreased self-rated health negatively (0.34, 0.12–0.97) related to the nonachievement of BP target level. Nonachievement of LDL-C target level was positively related to poor financial status (3.50, 1.19–10.28) and non-use of lipid-lowering medication (7.70, 4.07–14.56).
Conclusions
Nonachievement rates of the national treatment goals were high among older T2D patients, and nonachievement was related to use of medication, obesity, alcohol use, poor health, and poor financial status. We emphasize the importance of customized target setting by risk factor levels and active treatment.
期刊介绍:
The journal publishes original research articles and high quality reviews in the fields of clinical care, diabetes education, nutrition, health services, psychosocial research and epidemiology and other areas as far as is relevant for diabetology in a primary-care setting. The purpose of the journal is to encourage interdisciplinary research and discussion between all those who are involved in primary diabetes care on an international level. The Journal also publishes news and articles concerning the policies and activities of Primary Care Diabetes Europe and reflects the society''s aim of improving the care for people with diabetes mellitus within the primary-care setting.